On June 24th, 2020, the Shareholders of Seedo Corp. appointed Mr. David Grossman as Director, Dr. Gil Feiler as Executive Chairman, and David Freidenberg as Director. On the same date, Zohar Levy, previous Director, resigned. David Grossman, 45, has been Partner at Hava - Cannabis Ba'arava Ltd. since 2017. Director at Gefen Biomed Investments Ltd.; Chairmand and Board Member of Biomedico Hadarim Ltd.; Board Member at Beyond Air Inc.; Chairman of the Board and Chief Executive Officer at D-Pharm Ltd.; past External Director at Cellect Biotechnology Ltd.; Chairman of Algomizer Ltd.; CEO at XTL Biopharmaceuticals Ltd. Dr. Gil Feiler, 60, serves as the Director Bank of Georgia, Partner at Forest Investment House. Dr. Feiler serves as Head of Scientific Advisory Board of Cannabics Inc. He has served as a Board Member of Advanced Vision Technology (VSJ), the Board of Habenleumi Bank Mutual Fund Division (Dikla); advisor for the Government of Ras al-Khemah, United Arab Emirates. David Freidenberg, 43, has extensive experience in the telecommunications and information technology (IT) industries including Vice President of Sales & Business Development at Trigyn Technologies.